Meadow Creek Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-15,642
| Closed | -$98K | – | 1396 |
|
2018
Q3 | $98K | Buy |
15,642
+1,122
| +8% | +$7.03K | ﹤0.01% | 1229 |
|
2018
Q2 | $117K | Hold |
14,520
| – | – | ﹤0.01% | 1158 |
|
2018
Q1 | $108K | Buy |
14,520
+3,410
| +31% | +$25.4K | ﹤0.01% | 1185 |
|
2017
Q4 | $66K | Buy |
11,110
+2,816
| +34% | +$16.7K | ﹤0.01% | 1248 |
|
2017
Q3 | $61K | Buy |
8,294
+2,002
| +32% | +$14.7K | ﹤0.01% | 1236 |
|
2017
Q2 | $43K | Buy |
6,292
+3,366
| +115% | +$23K | ﹤0.01% | 1257 |
|
2017
Q1 | $28K | Buy |
+2,926
| New | +$28K | ﹤0.01% | 1258 |
|